Patents Assigned to Genome Institute of Singapore
  • Oligonucleotides, reagents and amplification methods for detecting severe acute respiratory syndrome coronavirus
    Patent number: 7527926
    Abstract: This invention provides oligonucleotides, reagents and amplification methods for detecting the severe acute respiratory syndrome coronavirus (SARS CoV). This invention also provides related compositions, kits, systems, and computers.
    Type: Grant
    Filed: April 21, 2004
    Date of Patent: May 5, 2009
    Assignee: Genome Institute of Singapore
    Inventors: Ee Chee Ren, Martin L. Hibberd, Lisa Fong Poh Ng
  • Inhibition of SARS coronavirus infection with clinically approved antiviral drugs
    Patent number: 7482149
    Abstract: The invention relates to methods for treating or inhibiting SARS-CoV infection involving the administration of an interferon, particularly IFN ?-n1, IFN ?-n3, human leukocyte IFN ? or IFN ?-1b.
    Type: Grant
    Filed: June 9, 2004
    Date of Patent: January 27, 2009
    Assignee: Genome Institute of Singapore
    Inventors: Emily Li Chuan Tan, Lawrence W. Stanton